Effectiveness of Thermal Ablation and Stereotactic Radiotherapy based on Stage I Lung Cancer Histology.

PURPOSE To assess whether the effectiveness of thermal ablation (TA) and stereotactic body radiotherapy (SBRT) as initial treatment for stage I lung cancer vary depending on the histological subtype. MATERIAL AND METHODS The 2004-2016 National Cancer Database was queried for patients with American Joint Committee on Cancer (AJCC) stage I lung cancer treated with TA or SBRT. Patients 0.1 each). CONCLUSIONS Overall survival following TA and SBRT for stage 1 lung cancer is comparable for most histological subtypes, except for longer OS following TA in non-small-cell neuroendocrine tumors.